{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:42Z","timestamp":1791389022596,"version":"4.3.3"},"reference-count":72,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":705,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1111\/jth.15074","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T14:41:55Z","timestamp":1607006515000},"page":"3174-3183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2407-9000","authenticated-orcid":false,"given":"Tzu\u2010Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Makar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Antic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-0394","authenticated-orcid":false,"given":"James D.","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-582X","authenticated-orcid":false,"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5810-6893","authenticated-orcid":false,"given":"Jeffrey I.","family":"Zwicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15074_bb0010","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer\u2010associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"16","author":"Samuelson Bannow","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15074_bb0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jth.14671","article-title":"The prevention and management of asparaginase\u2010related venous thromboembolism in adults: Guidance from the SSC on hemostasis and Malignancy of the ISTH","volume":"18","author":"Zwicker","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15074_bb0020","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all\u2010trans retinoic acid and idarubicin","volume":"111","author":"de la Serna","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0025","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15074_bb0030","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000\/microL versus 20,000\/microL","volume":"15","author":"Heckman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.15074_bb0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/bbmt.2002.v8.pm12434952","article-title":"A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000\/L versus 20,000\/microL trigger","volume":"8","author":"Zumberg","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/jth.15074_bb0040","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion"},{"key":"10.1111\/jth.15074_bb0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open\u2010label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/jth.15074_bb0050","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no\u2010prophylaxis platelet\u2010transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15074_bb0055","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/trf.12646","article-title":"Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial","volume":"54","author":"Stanworth","year":"2014","journal-title":"Transfusion"},{"key":"10.1111\/jth.15074_bb0060","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15074_bb0065","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: american society of clinical oncology clinical practice guideline update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.15074_bb0075","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15074_bb0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/trf.12395","article-title":"Utility of cross\u2010matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review","volume":"54","author":"Vassallo","year":"2014","journal-title":"Transfusion"},{"key":"10.1111\/jth.15074_bb0085","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/trf.12175","article-title":"Efficacy of HLA\u2010matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review","volume":"53","author":"Pavenski","year":"2013","journal-title":"Transfusion"},{"key":"10.1111\/jth.15074_bb0090","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1046\/j.1537-2995.2000.40121446.x","article-title":"Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity","volume":"40","author":"Petz","year":"2000","journal-title":"Transfusion"},{"key":"10.1111\/jth.15074_bb0095","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15074_bb0100","first-page":"265","article-title":"Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan","volume":"49","author":"Kobayashi","year":"1983","journal-title":"Bibl Haematol"},{"key":"10.1111\/jth.15074_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/jth.15074_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1160\/TH10-05-0293","article-title":"Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation","volume":"105","author":"Takemitsu","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15074_bb0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0609.2006.00711.x","article-title":"Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation","volume":"77","author":"Yanada","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15074_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2018.11.022","article-title":"A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation","volume":"173","author":"Luo","year":"2019","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15074_bb0125","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0145-2126(92)90084-K","article-title":"Bleeding complications and coagulopathy in acute leukaemia","volume":"16","author":"Tornebohm","year":"1992","journal-title":"Leuk Res"},{"key":"10.1111\/jth.15074_bb0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V79.5.1305.1305","article-title":"High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia","volume":"79","author":"Sarris","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0609.1993.tb00085.x","article-title":"A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972\u20131991","volume":"50","author":"Tornebohm","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15074_bb0140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0609.1995.tb01813.x","article-title":"Disseminated intravascular coagulation in acute leukaemias at first diagnosis","volume":"55","author":"Nur","year":"1995","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15074_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0609.1995.tb01623.x","article-title":"Disseminated intravascular coagulation (DIC) in adult patients with acute leukaemia","volume":"54","author":"Sletnes","year":"1995","journal-title":"Eur J Haematol"},{"issue":"1\u20102","key":"10.1111\/jth.15074_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10428199609067584","article-title":"Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg\/dl","volume":"21","author":"Sarris","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/jth.15074_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/10428199909145951","article-title":"Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment","volume":"36","author":"Chojnowski","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/jth.15074_bb0160","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/10428190500102662","article-title":"Disseminated intravascular coagulation complicating acute lymphoblastic leukemia: a study of childhood and adult cases","volume":"46","author":"Higuchi","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/jth.15074_bb0165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1076029607302435","article-title":"Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy","volume":"13","author":"Dixit","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.15074_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1532\/IJH97.06173","article-title":"Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation","volume":"86","author":"Uchiumi","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1111\/jth.15074_bb0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0609.2011.01747.x","article-title":"Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia","volume":"88","author":"Chang","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15074_bb0180","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12032-013-0478-y","article-title":"International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation >\/= 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia","volume":"30","author":"Mitrovic","year":"2013","journal-title":"Med Oncol"},{"key":"10.1111\/jth.15074_bb0185","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ijlh.12636","article-title":"A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D\u2010dimer levels are a sensitive indicator of acute promyelocytic leukemia","volume":"39","author":"Shahmarvand","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.15074_bb0195","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1365-2141.2000.01936.x","article-title":"Early haemorrhagic morbidity and mortality during remission induction with or without all\u2010trans retinoic acid in acute promyelocytic leukaemia","volume":"108","author":"Di Bona","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15074_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2004.11.001","article-title":"Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia\u2010a single center experience in 34 patients","volume":"116","author":"Dally","year":"2005","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15074_bb0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.2006.00803.x","article-title":"Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome","volume":"78","author":"Yanada","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15074_bb0210","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3324\/haematol.10874","article-title":"Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines","volume":"92","author":"Jacomo","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/jth.15074_bb0215","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3324\/haematol.2009.017962","article-title":"Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation","volume":"95","author":"Breccia","year":"2010","journal-title":"Haematologica"},{"key":"10.1111\/jth.15074_bb0220","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/j.leukres.2010.07.027","article-title":"Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy","volume":"34","author":"Serefhanoglu","year":"2010","journal-title":"Leuk Res"},{"key":"10.1111\/jth.15074_bb0225","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.leukres.2010.05.022","article-title":"Significance of fibrinogen, D\u2010dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia","volume":"35","author":"Kim","year":"2011","journal-title":"Leuk Res"},{"key":"10.1111\/jth.15074_bb0230","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/leu.2011.78","article-title":"Continuing high early death rate in acute promyelocytic leukemia: a population\u2010based report from the Swedish adult acute leukemia registry","volume":"25","author":"Lehmann","year":"2011","journal-title":"Leukemia"},{"key":"10.1111\/jth.15074_bb0235","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood-2016-10-747170","article-title":"Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era","volume":"129","author":"Mantha","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2019.102351","article-title":"Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone","volume":"79","author":"Hou","year":"2019","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/jth.15074_bb0245","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1080\/10428194.2019.1581187","article-title":"Predictors of early hemorrhage in acute promyelocytic leukemia","volume":"60","author":"Naymagon","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/jth.15074_bb0250","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-2001-18865","article-title":"Disseminated intravascular coagulation in acute leukemia","volume":"27","author":"Barbui","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.15074_bb0255","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1160\/TH15-09-0740","article-title":"Supportive management strategies for disseminated intravascular coagulation","volume":"115","author":"Squizzato","year":"2016","journal-title":"An international consensus. Thromb Haemost"},{"key":"10.1111\/jth.15074_bb0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15074_bb0265","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1988.tb04204.x","article-title":"Beneficial effect of heparin in the management of patients with APL","volume":"68","author":"Hoyle","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15074_bb0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0609.2004.00237.x","article-title":"Effective treatment of life\u2010threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia","volume":"72","author":"Zver","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15074_bb0275","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: anti\u2010inflammatory properties and clinical applications","volume":"115","author":"Levy","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15074_bb0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART\u2010123) in disseminated intravascular coagulation: results of a phase III, randomized, double\u2010blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15074_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.54","article-title":"Evaluation of coagulopathy before and during induction chemotherapy for acute lymphoblastic leukaemia, including assessment of global clotting tests","volume":"7","author":"Burley","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1111\/jth.15074_bb0290","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3324\/haematol.12948","article-title":"Changes in antithrombin and fibrinogen levels during induction chemotherapy with L\u2010asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study","volume":"93","author":"Hunault\u2010Berger","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jth.15074_bb0295","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajh.20230","article-title":"Thrombosis associated with L\u2010asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia","volume":"77","author":"Beinart","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.15074_bb0300","first-page":"328","article-title":"Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL\u20102005 study","volume":"136","author":"Orvain","year":"2020","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/ALN.0000000000001997","article-title":"Antifibrinolytic therapy and perioperative considerations","volume":"128","author":"Levy","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1111\/jth.15074_bb0310","first-page":"202a","article-title":"Antifibrinolytic therapy for bleeding control during remission induction for acute leukemia","volume":"62","author":"Gallardo","year":"1983","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0315","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(89)90181-5","article-title":"Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia","volume":"2","author":"Avvisati","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/jth.15074_bb0320","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10428199509059668","article-title":"A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia","volume":"19","author":"Shpilberg","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/jth.15074_bb0325","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0609.1990.tb00423.x","article-title":"Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions","volume":"45","author":"Ben\u2010Bassat","year":"1990","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.15074_bb0330","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1365-2141.2000.02270-8.x","article-title":"All\u2010trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia","volume":"110","author":"Brown","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15074_bb0335","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncr.21958","article-title":"Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage","volume":"107","author":"Kalmadi","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/jth.15074_bb0340","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hon.867","article-title":"Acute promyelocytic leukaemia and acquired alpha\u20102\u2010plasmin inhibitor deficiency: a retrospective look at the use of epsilon\u2010aminocaproic acid (Amicar) in 30 patients","volume":"26","author":"Wassenaar","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1111\/jth.15074_bb0345","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/cncr.28253","article-title":"Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies","volume":"119","author":"Antun","year":"2013","journal-title":"Cancer"},{"key":"10.1111\/jth.15074_bb0350","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hon.2189","article-title":"Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series","volume":"34","author":"Marshall","year":"2016","journal-title":"Hematol Oncol"},{"key":"10.1111\/jth.15074_bb0355","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1080\/10428194.2018.1434882","article-title":"Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies","volume":"59","author":"Juhl","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/jth.15074_bb0360","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood.V75.11.2112.2112","article-title":"Early deaths and anti\u2010hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients","volume":"75","author":"Rodeghiero","year":"1990","journal-title":"Blood"},{"key":"10.1111\/jth.15074_bb0365","first-page":"CD009733","article-title":"Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders","volume":"3","author":"Estcourt","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15074","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15074","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622037643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622037643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:26:01Z","timestamp":1761535561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622037643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1538783622037643"],"URL":"https:\/\/doi.org\/10.1111\/jth.15074","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}